| ANTIPSYCHOTICS' RISK MEASUREMENT IN EUROPE |
|
ANTIPSYCHOTICS' RISK REDUCTION IN EUROPE
|
|
TIMELY DIAGNOSIS & ANTIPSYCHOTICS |
|
ETHICS IN PRACTICE & ANTIPSYCHOTICS |
|
Being chronically exposed to antipsychotics in Alzheimer's disease leads to increased severe side effects risk; it is crucial to measure & monitor this risk
|
Different strategies have been implemented in Europe to limit the prescription of antipsychotics & then the risk of exposure in dementia
|
The diagnosis of the disease could be an opportunity to plan the prevention of the overuse of antipsychotics
|
The use of AP must be analyzed from several ethical perspectives: e.g. distinguishing situations where AP are used in response to particular symptoms & where they are used as a form of restraint (as an alternative to physical restraint)
|
